Literature DB >> 25156722

Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

David Montero1, Paz Orellana1, Daniela Gutiérrez1, Daniela Araya1, Juan Carlos Salazar1, Valeria Prado1, Angel Oñate2, Felipe Del Canto1, Roberto Vidal3.   

Abstract

Shiga-toxin producing Escherichia coli (STEC) is the etiologic agent of acute diarrhea, dysentery, and hemolytic-uremic syndrome (HUS). There is no approved vaccine for STEC infection in humans, and antibiotic use is contraindicated, as it promotes Shiga toxin production. In order to identify STEC-associated antigens and immunogenic proteins, outer membrane proteins (OMPs) were extracted from STEC O26:H11, O103, O113:H21, and O157:H7 strains, and commensal E. coli strain HS was used as a control. SDS-PAGE, two-dimensional-PAGE analysis, Western blot assays using sera from pediatric HUS patients and controls, and matrix-assisted laser desorption ionization-tandem time of flight analyses were used to identify 12 immunogenic OMPs, some of which were not reactive with control sera. Importantly, seven of these proteins have not been previously reported to be immunogenic in STEC strains. Among these seven proteins, OmpT and Cah displayed IgG and IgA reactivity with sera from HUS patients. Genes encoding these two proteins were present in a majority of STEC strains. Knowledge of the antigens produced during infection of the host and the immune response to those antigens will be important for future vaccine development.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156722      PMCID: PMC4249345          DOI: 10.1128/IAI.02030-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  87 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

Review 2.  Prospects for a group A streptococcal vaccine.

Authors:  David J McMillan; Gursharan S Chhatwal
Journal:  Curr Opin Mol Ther       Date:  2005-02

3.  Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

Authors:  Manohar John; Indira T Kudva; Robert W Griffin; Allen W Dodson; Bethany McManus; Bryan Krastins; David Sarracino; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Phillip I Tarr; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  L-asparaginase II of Escherichia coli. Studies on the enzymatic mechanism of action.

Authors:  M Ehrman; H Cedar; J H Schwartz
Journal:  J Biol Chem       Date:  1971-01-10       Impact factor: 5.157

6.  Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics.

Authors:  T A Prokhorova; P N Nielsen; J Petersen; T Kofoed; J S Crawford; C Morsczeck; A Boysen; P Schrotz-King
Journal:  Vaccine       Date:  2006-06-12       Impact factor: 3.641

7.  Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.

Authors:  Koji Hase; Lars Eckmann; John D Leopard; Nissi Varki; Martin F Kagnoff
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.

Authors:  Rebecca A Brady; Jeff G Leid; Anne K Camper; J William Costerton; Mark E Shirtliff
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

9.  Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins.

Authors:  Dominique Granato; Gabriela E Bergonzelli; Raymond David Pridmore; Laure Marvin; Martine Rouvet; Irène E Corthésy-Theulaz
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.

Authors:  Wildaliz Nieves; Julie Heang; Saja Asakrah; Kerstin Höner zu Bentrup; Chad J Roy; Lisa A Morici
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

View more
  12 in total

Review 1.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

3.  TleA, a Tsh-like autotransporter identified in a human enterotoxigenic Escherichia coli strain.

Authors:  Daniela Gutiérrez; Mirka Pardo; David Montero; Angel Oñate; Mauricio J Farfán; Fernando Ruiz-Pérez; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

4.  EF-Tu From Non-typeable Haemophilus influenzae Is an Immunogenic Surface-Exposed Protein Targeted by Bactericidal Antibodies.

Authors:  Oskar Thofte; Yu-Ching Su; Marta Brant; Nils Littorin; Benjamin Luke Duell; Vera Alvarado; Farshid Jalalvand; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

5.  Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Javier I Sanchez-Villamil; Daniel Tapia; Alfredo G Torres
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

6.  Role of Lipopolysaccharide in Protecting OmpT from Autoproteolysis during In Vitro Refolding.

Authors:  Gaurav Sinsinbar; Sushanth Gudlur; Kevin J Metcalf; Milan Mrksich; Madhavan Nallani; Bo Liedberg
Journal:  Biomolecules       Date:  2020-06-18

7.  Locus of Adhesion and Autoaggregation (LAA), a pathogenicity island present in emerging Shiga Toxin-producing Escherichia coli strains.

Authors:  David A Montero; Juliana Velasco; Felipe Del Canto; Jose L Puente; Nora L Padola; David A Rasko; Mauricio Farfán; Juan C Salazar; Roberto Vidal
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

Review 8.  Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.

Authors:  Maricarmen Rojas-Lopez; Ricardo Monterio; Mariagrazia Pizza; Mickaël Desvaux; Roberto Rosini
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

9.  Determination of virulence and fitness genes associated with the pheU, pheV and selC integration sites of LEE-negative food-borne Shiga toxin-producing Escherichia coli strains.

Authors:  Nadja Saile; Elisabeth Schuh; Torsten Semmler; Inga Eichhorn; Lothar H Wieler; Andreas Bauwens; Herbert Schmidt
Journal:  Gut Pathog       Date:  2018-10-08       Impact factor: 4.181

10.  Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli.

Authors:  David A Montero; Felipe Del Canto; Juan C Salazar; Sandra Céspedes; Leandro Cádiz; Mauricio Arenas-Salinas; José Reyes; Ángel Oñate; Roberto M Vidal
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.